Table 2.
Patient | Age (years) | Discharge diagnosis | Acinetobacter species | Maximum temp. (°C)† | WBC‡ at admission | Antibiotic Therapy | Susceptibility of isolate to antibiotic used for treatment | Outcome |
---|---|---|---|---|---|---|---|---|
1 | <1 | Burn and surgical debridement§ | Acb complex | 41·0 | 14 520 | Cloxacillin | Resistant | Survived |
2 | <1 | Pneumonia | Acb complex | 39·1 | 15 100 | Ampicillin | Resistant | Survived |
3 | <1 | Pneumonia | Acb complex | 38·9 | – | Amoxicillin | Susceptible to amoxicilin | Survived |
Ceftriaxone | Susceptible to cefotaxime | |||||||
4 | 1–<5 | Pneumonia | Acb complex | 40·0 | – | Ampicillin | Resistant | Survived |
Ceftriaxone | Resistant to cefotaxime | |||||||
5 | 1–<5 | Diarrhoea | Non-Acb complex | 38·0 | – | None noted | – | Survived |
6 | 1–<5 | Pneumonia | Non-Acb complex | 38·4 | – | Amoxicillin/clavulanate | Susceptible to amoxicillin | Survived |
Ampicillin | Susceptible to ampicillin | |||||||
7 | 1–<5 | Pneumonia | Non-Acb complex | 38·8 | 20 700 | Amoxicillin | Susceptible to amoxicillin | Survived |
Ceftriaxone | Susceptible to cefotaxime | |||||||
8 | 1–<5 | Pneumonitis | Acb complex | 39·9 | 11 100 | Amoxicillin | Susceptibility unknown | Survived |
Ceftriaxone | ||||||||
9 | 1–<5 | Fever | Non-Acb complex | 40·0 | 27 090 | Amoxicillin | Susceptible to amoxicillin | Survived |
Ceftazadime | Ceftazadime unknown | |||||||
Ceftriaxone | Susceptible to cefotaxime | |||||||
10 | 5–15 | Acute bronchitis | Non-Acb complex | 40·3 | 2100 | Ampicillin | Resistant to ampicillin | Survived |
Cephalexin | Susceptibility to cephalexin unknown | |||||||
11 | 5–15 | Septicaemia | Acb complex | 39·6 | 6100 | Ampicillin | Resistant to ampicillin | Survived |
Ciprofloxacin | Ciprofloxacin unknown | |||||||
Gentamicin | Susceptible to gentamicin | |||||||
12 | 5–15 | Fever | Non-Acb complex | 39·0 | 8400 | None noted | – | Survived |
13 | 5–15 | Viral infection | Acb complex | 38·1 | 3400 | None noted | – | Survived |
14 | 5–15 | Cellulitis | Non-Acb complex | 39·9 | 18 000 | Ceftazidime | Resistant to cefotaxime | Survived |
Ceftriaxone | Ceftriaxone unknown | |||||||
Clindamycin | Clindamycin unknown | |||||||
Roxithromycin | Roxithromycin unknown | |||||||
Co-trimoxazole | Resistant to trimethoprim | |||||||
15 | 5–15 | Acute pharyngitis | Non-Acb complex | 38·7 | 6600 | Amoxicillin | Susceptible | Survived |
Acb, Acinetobacter calcoaceticus–baumannii.
Non-HCA indicates that the blood culture was collected <3 days after admission and the patient had no known HCA risk factors.
Maximum temperature during first 24 h of admission.
White blood cell count/mm3.
This child was hospitalized with second-degree scald burn of right forearm, the following day he developed high fever and had a seizure during surgical debridement.